Subventions financées

Brain cancer is the most common type of solid cancer in children in Canada, and medulloblastoma is the most common malignant brain cancer of childhood.

A treatment or prevention of Alzheimer’s disease is a top priority for medical science.

One percent of Alzheimer’s disease is the early-onset type that runs in families.

One of the most important advances in our understanding of chronic pain over the last decade or so is the realization that neurons are not the only cells in the central nervous system participating in the processing of pain signals.

Noninvasive brain stimulation is gaining acceptance as an alternate therapy for an increasing number of disorders, including major depression, schizophrenia, stroke and Parkinson’s disease.

Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for patients with depression who have not responded to antidepressant medications.

Sight is the most precious sense, and patients suffering vision loss endure a devastating experience. Blindness often results from the gradual death of photoreceptors, the retinal cells that perceive light.

500,000 Canadians have dementia, a number that will double within a generation due to the ongoing aging demographics of the population, with annual costs estimated to increase from $15B currently to over $150B by the year 2050.

Ms. Nancy Butcher, is a doctoral candidate who is conducting research using advanced brain imaging techniques to measure levels of the brain chemical dopamine, to differentiate between Parkinson’s disease and other motor neuron defects.

The CIFAR Learning in Machines & Brains program brings together 41 researchers to examine what consciousness is and how it comes about.